ECO Animal Health is trying to shift from relying on a single livestock antibiotic to a bigger, higher-quality mix of preventative products like vaccines, but the first major launch still looks a long way off. If approvals, manufacturing, or partners slip—or farm economics turn against producers in key regions—the business may struggle to turn its research pipeline into steadier growth.Read more
Catalysts About ECO Animal Health Group ECO Animal Health Group develops and commercializes pharmaceutical and biological products that improve the health and productivity of food producing animals worldwide. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About ECO Animal Health Group ECO Animal Health Group develops and commercializes animal health medicines and vaccines focused on controlling infectious disease in livestock globally. What are the underlying business or industry changes driving this perspective?Read more
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.
